70121-2702 Boncresa - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

70121-2702

Brand Name:

Boncresa

Generic Name:

Denosumab-mobz

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Subcutaneous

Substances:

Name: DENOSUMAB

Strength: 60.0

Unit: mg/mL

Packages:

Code: 70121-2702-01

Description: 1 SYRINGE in 1 CARTON (70121-2702-1) / 1 mL in 1 SYRINGE

Effective Date: Dec. 23, 2025

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

RANKL

Orphan Drug Designation:

Status:

In Use